Chief Commercial Officer · MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Rebecca Buzzeo

FY2024 is the first fiscal year CompBrief holds for Rebecca Buzzeo as a named executive officer of MARAVAI LIFESCIENCES; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,459,680

Salary $465,231Stock awards $1,853,113Bonus $46,800

3rd of 5 named executive officers at Maravai Lifesciences by FY2024 total.

5 named officers on file for MARAVAI LIFESCIENCES, FY2024

Rebecca Buzzeo’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing
  • MRVI’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how MARAVAI LIFESCIENCES’s whole pay program stands against its peers

  • MARAVAI LIFESCIENCES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MRVI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 18, 2025 (DEF 14A).

Free

Get Rebecca Buzzeo’s full pay file as a PDF — free

More than this page: up to 10 years of Rebecca’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Rebecca Buzzeo compensation by year

MARAVAI LIFESCIENCES Summary Compensation Table · the one fiscal year held
In US dollars, as MARAVAI LIFESCIENCES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$465,231
Bonus$46,800
Stock awards$1,853,113
Option awards$0
Non-equity incentive$94,536
Pension and deferred compensation$0
All other$0
Total$2,459,680

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MARAVAI LIFESCIENCES HOLDINGS, INC. DEF 14A filed April 18, 2025, accession 0001193125-25-085761, and prior-year filings. Open the filing on EDGAR.

How this page was built: the MARAVAI LIFESCIENCES HOLDINGS, INC. filed document, accession 0001193125-25-085761. Every figure is read from that document and cited to the page and table it appears in. Filed April 18, 2025.

Change-in-control & termination

estimated payments MARAVAI LIFESCIENCES discloses, by trigger · FY2024
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$702,000$0$7,964$709,964
Change in control and involuntary termination$1,638,000$1,803,999$11,946$3,453,945

Per the Potential Payments Upon Termination or Change in Control table in MARAVAI LIFESCIENCES HOLDINGS, INC.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.

MARAVAI LIFESCIENCES’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
William MartinChief Executive Officer$6,380,399
Andrew BurchFormer President, Nucleic Acid Production$2,558,244
Rebecca Buzzeo · this pageChief Commercial Officer$2,459,680
Peter LeddyChief Administrative Officer$2,363,764
Kevin HerdeChief Financial Officer$2,339,364

The full MARAVAI LIFESCIENCES compensation record

free company brief

This page is one person within MARAVAI LIFESCIENCES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the MARAVAI LIFESCIENCES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MARAVAI LIFESCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Rebecca Buzzeo's compensation dossier · One-time report. No refunds.